Microneedling: what the evidence actually shows
Medically reviewed by:
Dr Priya Verma
MRCGP, MBChB, DRCOG, DFSRH, PGDip Aesthetics, BSc (Hons) Biomedical Science
Educational only, not medical advice · Prices indicative
AT A GLANCE
Skin of colour: Safe across all tones, a genuine advantage.
DOWNTIME
1-3 Days
redness, like mild sunburn
SESSIONS
3-6 Sessions
4-6 weeks apart
RESULTS
Glow by week 2-3
scars - from month 3
DISCOMFORT
3-5 / 10
with numbing cream
PRICE
£100-£350 session
Course £300–£1,800
Reversible? No. Collagen remodelling is cumulative.
WHAT IT IS
A controlled micro-injury that asks the skin to rebuild
Microneedling, also called collagen induction therapy, uses a motorised pen or roller fitted with very fine, sterile needles to create tiny, controlled punctures. Those micro-injuries trigger the skin’s natural wound-healing cascade: old collagen is remodelled and new collagen and elastin are laid down. Over weeks and months, the skin gradually becomes denser, smoother and more even.
The devices used in UK clinics are CE or UKCA-marked medical devices. The most studied is SkinPen Precision, which in 2016 became the first microneedling device to receive FDA De Novo clearance specifically for facial acne scars, across all skin tones. Needle depth is adjusted per area and concern, typically 0.5–2.5 mm in clinic, always guided by the practitioner.
This page covers mechanical, non-radiofrequency microneedling only. RF microneedling (Morpheus8, Potenza and similar) combines needling with radiofrequency energy and is a different treatment with its own page.
The FDA safety communication of 15 Oct 2025 covers RF only, it does not apply here.
01 · Controlled punctures
Tiny microchannels
Very fine, sterile needles create controlled punctures at a depth selected for the area and concern.
02 · Repair signal
Fibroblast activity
The skin reads the controlled injury as a repair signal. Fibroblasts and growth-factor pathways begin the wound-healing response.
03 · Remodelling
New collagen and elastin
Over weeks and months, old collagen is remodelled and the skin gradually becomes denser, smoother and more even.
HOW IT WORKS
Like aerating a lawn: repair by controlled signal
The tiny punctures, each about the width of a human hair, signal to the skin that repair is needed. Fibroblasts, the cells that build the skin’s scaffolding, are recruited and deposit new collagen, elastin and hyaluronic acid. Because the epidermis is largely bypassed rather than destroyed, the pigment-producing melanocytes are minimally disturbed, which is why microneedling has such a favourable record across all skin tones.
The FDA safety communication of 15 Oct 2025 covers RF only, it does not apply here.
DEPTH OF ACTION
The needle works in the dermis, depth adjustable from roughly 0.5 to 2.5 mm, where the collagen-building fibroblasts sit. The surface is largely spared, which is why it stays safe across all skin tones.
STEP 1
Prime
STEP 2
Needle
STEP 3
Heal
THE HONEST CEILING
What it won't do
WHAT IT CAN DO
- Soften rolling and boxcar acne scars over a course
- Improve texture, glow and overall skin quality
- Help early red stretch marks more than mature white ones
- Work safely across all Fitzpatrick skin tones
WHAT IT CANNOT DO
- Fix ice-pick scars, these need TCA CROSS or punch methods
- Transform your skin in a single session
- Match ablative laser for deep or extensive scarring
- Lift sagging skin or soften dynamic expression lines
BY CONCERN
One treatment, several honest answers
ACNE SCARS
Rolling & boxcar scars
The primary and best-evidenced use. A 2021 systematic review of nine independent RCTs (341 participants) and a 2022 meta-analysis of twelve RCTs (414 patients) both found meaningful, well-tolerated improvement in atrophic scars, corroborated by a 2024 network meta-analysis of 24 studies. Rolling and boxcar scars respond best; ice-pick scars respond poorly and need a different technique.
Expect gradual change over a course of three to six sessions, with the most visible improvement three to six months after finishing. Treat active acne first, as needling over breakouts risks spreading infection and new scarring.
View the evidence · 4 studies + FDA clearance
- Sitohang IBS et al., International Wound Journal, 2021. This systematic review included nine randomised controlled trials with 341 participants. It was independently academically funded. The authors concluded that microneedling was well tolerated and effective for atrophic acne scars, with no serious adverse effects reported.
- Shen Y-C et al., Aesthetic Plastic Surgery, 2022. This meta-analysis included twelve randomised controlled trials involving 414 participants. It was independently academically funded. The pooled improvement was statistically significant, supporting acne scarring as the indication with the strongest evidence base for microneedling.
- Mattioli et al., Aesthetic Medicine, 2024. This independently funded literature review corroborated the well-established evidence tier for microneedling in the treatment of acne scars and for broader skin-quality outcomes.
- Archives of Dermatological Research, 2026. This independently funded systematic review and meta-analysis found corroborating evidence for combined microneedling and platelet-rich plasma treatment. Its findings support a Well Established evidence tier.
- FDA De Novo DEN160029, SkinPen Precision, 2016. This regulatory clearance covers the treatment of facial acne scars in adults aged 22 and over across all Fitzpatrick skin types.
STRETCH MARKS
Striae: red respond, white resist
A developing evidence base: a 2024 systematic review and meta-analysis (11 articles, 6 RCTs) found statistically significant improvement. The distinction that matters is timing. Early red striae respond substantially better than mature white ones, where improvement typically sits below around 30%.
If your marks are still pink or red, this is the window to explore treatment. Body areas are usually priced higher than the face.
View the evidence · 3 studies
- Systematic review and meta-analysis, 2024. This review pooled eleven articles, including six randomised controlled trials, and found statistically significant improvement in striae distensae with microneedling. Improvement was consistently greater for early red striae than for mature white ones.
- Park KY et al., Dermatologic Surgery, 2012. This early prospective needling study in sixteen patients with striae distensae reported clinical improvement in most participants with good tolerability, establishing proof of concept for the indication.
- Within the pooled 2024 analysis, reported improvement for mature white striae typically sat below around thirty percent, versus substantially better responses in early red striae. This timing effect is the basis for the guidance on this page.
HAIR THINNING
Scalp needling: a minoxidil adjunct
An adjunct, never a standalone. The landmark 2013 Dhurat RCT and several later meta-analyses found a significant benefit for microneedling plus minoxidil over minoxidil alone. But a large 2026 RCT of 245 women, the biggest to date, found no statistically significant added benefit, which meaningfully tempers the enthusiasm.
Reasonable to discuss with a prescribing practitioner as an add-on to medical treatment; not established as a primary therapy. Hair loss needs medical triage first.
View the evidence · 4 studies
- Dhurat R et al., International Journal of Trichology, 2013. This randomised evaluator-blinded trial of 100 men with androgenetic alopecia found microneedling plus topical minoxidil produced significantly greater hair regrowth than minoxidil alone. It was independently academically funded.
- Fertig RM et al., Journal of the European Academy of Dermatology and Venereology, 2018. This review of microneedling for hair loss summarised proposed mechanisms and early trial evidence, concluding the approach was promising as an adjunct while calling for larger controlled trials.
- Meta-analyses of subsequent randomised trials pooled the microneedling-plus-minoxidil comparison and reported a statistically significant added benefit over minoxidil alone, though the constituent trials were small and heterogeneous.
- Randomised controlled trial, 2026. The largest trial to date, in 245 women, found no statistically significant added benefit from microneedling over topical treatment alone, which meaningfully tempers earlier enthusiasm and is reflected in the evidence tier for this indication.
SKIN OF COLOUR
Safe across all skin tones, and the science explains why
The FDA De Novo clearance for SkinPen explicitly includes all Fitzpatrick types. In practice, the standard protocol, including appropriate depth, single-use sterile cartridges and clean technique, is the same for Fitzpatrick I as for VI, without the conservative downgrading other procedures require.
RESULTS TIMELINE
What you'll see, and when
REAL PEOPLE
What the aggregate reviews say
WORTH IT · 421 REVIEWS
FREQUENTLY ASKED QUESTIONS